Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
Clinical trial NCT02101333 · COMPLETED
Trial details
- NCT number
- NCT02101333
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-10
- Primary completion
- 2018-12-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.